kanglaite

Small moleculeexperimental

Clinical trial activity

7 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
2

Earliest trial started Jun 1, 2001 (NCT00031031)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • kanglaite
  • kanglaite
  • kang-lai-te

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03986528Phase 4Jun 15, 2019China Academy of Chinese Medical Sciences, Government of China
NCT03101514Phase 2Jan 1, 2017Harbin Medical University
NCT02553187Phase 4Sep 1, 2015H & J CRO International, Inc., Huazhong University of Science and Technology, Zhejiang Kanglaite Pharmaceutical Co.Ltd
NCT01640730Phase 2May 1, 2012Zhejiang Kanglaite Pharmaceutical Co.Ltd
NCT01483586Phase 2Nov 1, 2011Zhejiang Kanglaite Pharmaceutical Co.Ltd
NCT00733850Phase 2Aug 1, 2008University of Tennessee, Zhejiang Kanglaite Pharmaceutical Co.Ltd
NCT00031031Phase 1Jun 1, 2001University of Utah, Zhejiang Kanglaite Pharmaceutical Co.Ltd
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Zhejiang Kanglaite Pharmaceutical Co.LtdFor profit5532001
China Academy of Chinese Medical SciencesAcademic/Hospital1112019
Government of ChinaGovernment1012019
Harbin Medical UniversityAcademic/Hospital1112017
H & J CRO International, Inc.For profit1012015
Huazhong University of Science and TechnologyAcademic/Hospital1012015
University of TennesseeAcademic/Hospital1012008
University of UtahAcademic/Hospital1012001
8 organizations
Page 1 / 1